Ann: Quickstep completes A$10m capital investment in Bankstown, page-4

I think Waurn Ponds spend will depend on new projects ramping up, the two recent grants are likely to be the main funding source for R&D associated with nearer term production so shouldn't see a major increase in near term non-aerospace R&D.

If they find the cure for cancer obviously, R&D spend previously unaccounted for may rise up. Otherwise, it's now time to see the aerospace profits kick in.

Musing to myself, we should probably expect another announcement in the near term regarding KIST delivery and payment received.

Finally, my suggestion for getting the board leaner is for them to lighten their wallets into some "unacceptably" cheap shares. This is my one remaining negative against this share.

I sure as hell think its going cheap.

Management say the same:
"...our share price performance has not been acceptable since the capital raise..."

...yet I dont see them putting in for more shares (I have to clarify I believe Air Marshal McCormack did chip in a cool 100,000+ in Nov. last year)